Ten-year incidence and impact of coronavirus infections on incidence, etiology, and antimicrobial resistance of healthcare-associated infections in a critical care unit in Western Qatar.
COVID-19
Healthcare-associated infections
Qatar
antimicrobial resistance
device-associated infections
etiology
incidence
intensive care unit
Journal
Qatar medical journal
ISSN: 0253-8253
Titre abrégé: Qatar Med J
Pays: Qatar
ID NLM: 8101648
Informations de publication
Date de publication:
2023
2023
Historique:
received:
05
08
2022
accepted:
30
10
2022
medline:
31
7
2023
pubmed:
31
7
2023
entrez:
31
7
2023
Statut:
epublish
Résumé
Healthcare-associated infections (HAI) in critical patients affect the quality and safety of patient care as they impact morbidity and mortality. During the COVID-19 pandemic, an increase in the incidence rate was reported worldwide. We aim to describe the incidence of HAI in the intensive care unit (ICU) during a 10-year follow-up period and compare the incidence during the pre-COVID-19 and COVID-19 periods. A retrospective observational study of HAI in the medical-surgical ICU at The Cuban Hospital was conducted. The data collected include the annual incidence of HAI, its etiology, and antimicrobial resistance, using the Centers for Disease Control and Prevention definitions, except for other respiratory tract infections (RTIs). A total of 155 patients had HAI, of which 130 (85.5%) were identified during COVID-19. The frequency of device-associated infections (DAI) and non-DAI was higher during COVID-19, except for The incidence of DAI increased during the pandemic period as compared to the pre-pandemic period, and limited evidence of the impact on antimicrobial resistance was observed. The infection control program should evaluate strategies to minimize the impact of pandemics on HAI.
Sections du résumé
BACKGROUND
BACKGROUND
Healthcare-associated infections (HAI) in critical patients affect the quality and safety of patient care as they impact morbidity and mortality. During the COVID-19 pandemic, an increase in the incidence rate was reported worldwide. We aim to describe the incidence of HAI in the intensive care unit (ICU) during a 10-year follow-up period and compare the incidence during the pre-COVID-19 and COVID-19 periods.
METHODS
METHODS
A retrospective observational study of HAI in the medical-surgical ICU at The Cuban Hospital was conducted. The data collected include the annual incidence of HAI, its etiology, and antimicrobial resistance, using the Centers for Disease Control and Prevention definitions, except for other respiratory tract infections (RTIs).
RESULTS
RESULTS
A total of 155 patients had HAI, of which 130 (85.5%) were identified during COVID-19. The frequency of device-associated infections (DAI) and non-DAI was higher during COVID-19, except for
CONCLUSION
CONCLUSIONS
The incidence of DAI increased during the pandemic period as compared to the pre-pandemic period, and limited evidence of the impact on antimicrobial resistance was observed. The infection control program should evaluate strategies to minimize the impact of pandemics on HAI.
Identifiants
pubmed: 37521091
doi: 10.5339/qmj.2023.11
pii: qmj.2023.11
pmc: PMC10375912
doi:
Types de publication
Journal Article
Langues
eng
Pagination
11Informations de copyright
© 2023 Garcell, Al-Ajmi, Arias, Abraham, Garmendia, Hernandez, licensee HBKU Press.
Références
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):495-502
pubmed: 33389263
Am J Infect Control. 2021 Oct;49(10):1267-1274
pubmed: 33901588
J Vasc Access. 2021 Jan;22(1):34-41
pubmed: 32406328
J Hosp Infect. 2021 May;111:27-34
pubmed: 33716086
Am J Infect Control. 2015 Mar 1;43(3):206-21
pubmed: 25575913
Infect Control Hosp Epidemiol. 2022 Jan;43(1):12-25
pubmed: 34473013
Semin Respir Crit Care Med. 2022 Apr;43(2):243-247
pubmed: 35042264
Am J Infect Control. 2020 Nov;48(11):1409-1411
pubmed: 32621857
Int J Infect Dis. 2020 Nov;100:386-389
pubmed: 32949777
Clin Infect Dis. 2022 May 30;74(10):1748-1754
pubmed: 34370014
Infect Control Hosp Epidemiol. 2022 Jan;43(1):26-31
pubmed: 33602361
BMJ Open Qual. 2021 Feb;10(1):
pubmed: 33597274
Biomed Res Int. 2016;2016:8231787
pubmed: 27382571
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
J Fungi (Basel). 2021 Mar 23;7(3):
pubmed: 33807036
J Hosp Infect. 2017 Nov;97(3):260-266
pubmed: 28716670
J Epidemiol Glob Health. 2018 Mar;7 Suppl 1:S35-S40
pubmed: 29801591
Am J Infect Control. 2013 Dec;41(12):1148-66
pubmed: 24274911
Int J Antimicrob Agents. 2021 Apr;57(4):106324
pubmed: 33746045
Int J Infect Dis. 2022 May;118:83-88
pubmed: 35218928
Clin Microbiol Infect. 2021 Jan;27(1):83-88
pubmed: 32745596
J Infect Public Health. 2014 Jul-Aug;7(4):339-44
pubmed: 24861643
Intensive Care Med. 2021 Feb;47(2):188-198
pubmed: 33388794
Open Forum Infect Dis. 2021 Nov 16;8(12):ofab510
pubmed: 34877364
Am J Infect Control. 2021 Jun;49(6):657-662
pubmed: 33775741
Antimicrob Resist Infect Control. 2021 Jun 4;10(1):87
pubmed: 34088341
World Med Health Policy. 2021 Dec;13(4):766-772
pubmed: 34909239
Am J Infect Control. 2020 Sep;48(9):1130-1131
pubmed: 32593810